Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Implication of Plasma Circulating Tumor DNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas: a Multicenter, Cohort Study

NCT03737591 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03737591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03737591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Implication of Plasma Circulating Tumor DNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas: a Multicenter, Cohort Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
May 1, 2010
Completion date
December 31, 2021
Enrollment
1,138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma, colorectal cancer